Altimmune, Inc. — Director's Dealing 2020

Oct 17, 2020

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Altimmune, Inc. (ALT)
CIK: 0001326190
Period of Report: 2020-09-24

Reporting Person: Schafer Klaus (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2020-09-24	Common Stock, par value $0.0001	M	16850	$0.00	Acquired	17050	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2020-09-24	Restricted Stock Units ("RSUs")	$	M	16850	Disposed		Common Stock (16850)	Direct

Footnotes

F1: Each RSU represents a contingent right to receive one share of Common Stock, par value $0.0001, when vested.

F2: On June 25, 2020, the reporting person was granted 16,850 restricted stock units, which vested in full at the Company's 2020 annual meeting of stockholders on September 24, 2020.